Literature DB >> 14726076

Stair climbing test as a predictor of cardiopulmonary complications after pulmonary lobectomy in the elderly.

Alessandro Brunelli1, Marco Monteverde, Majed Al Refai, Aroldo Fianchini.   

Abstract

BACKGROUND: The objective of this study was to assess the role of a symptom-limited stair climbing test in predicting postoperative cardiopulmonary complications in elderly candidates for lung resection.
METHODS: A consecutive series of 109 patients more than 70 years of age who underwent pulmonary lobectomy for lung carcinoma from January 2000 through May 2003 formed the prospective database of this study. All patients in the analysis performed a preoperative symptom-limited stair climbing test. Univariate and multivariate analyses were performed to identify predictors of postoperative cardiopulmonary complications.
RESULTS: At univariate analysis, the patients with complications had a lower forced expiratory capacity percentage of predicted (p = 0.048), predicted postoperative forced expiratory volume in 1 second percentage of predicted (p = 0.049), climbed a lower height at preoperative stair climbing test (p = 0.0004), and presented a greater proportion of cardiac comorbiditiy with respect to the patients without complications (p = 0.02). After logistic regression analysis, significant predictors of postoperative complications resulted in the presence of a concomitant cardiac disease (p = 0.04) and a low height climbed preoperatively (p = 0.0015).
CONCLUSIONS: A symptom-limited stair climbing test was a safe and simple instrument capable of predicting cardiopulmonary complications in the elderly after lung resection.

Entities:  

Mesh:

Year:  2004        PMID: 14726076     DOI: 10.1016/s0003-4975(03)01327-4

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

Review 1.  Risk assessment of lung resection for lung cancer according to pulmonary function: republication of systematic review and proposals by guideline committee of the Japanese association for chest surgery 2014.

Authors:  Noriyoshi Sawabata; Takashi Nagayasu; Yoshihisa Kadota; Taichiro Goto; Hiroyoshi Horio; Takeshi Mori; Shinichi Yamashita; Akinori Iwasaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-09-27

2.  The Walking Impairment Questionnaire stair-climbing score predicts mortality in men and women with peripheral arterial disease.

Authors:  Atul Jain; Kiang Liu; Luigi Ferrucci; Michael H Criqui; Lu Tian; Jack M Guralnik; Huimin Tao; Mary M McDermott
Journal:  J Vasc Surg       Date:  2012-06       Impact factor: 4.268

Review 3.  [Perioperative pharmacological myocardial protection. Systematic literature-based process optimization].

Authors:  M Petzoldt; J Kähler; A E Goetz; P Friederich
Journal:  Anaesthesist       Date:  2008-07       Impact factor: 1.041

Review 4.  Association of lower extremity performance with cardiovascular and all-cause mortality in patients with peripheral artery disease: a systematic review and meta-analysis.

Authors:  Dylan R Morris; Alexander J Rodriguez; Joseph V Moxon; Margaret A Cunningham; Mary M McDermott; Jonathan Myers; Nicholas J Leeper; Rhondda E Jones; Jonathan Golledge
Journal:  J Am Heart Assoc       Date:  2014-08-13       Impact factor: 5.501

5.  Cancer-driven changes link T cell frequency to muscle strength in people with cancer: a pilot study.

Authors:  Aditi Narsale; Rosa Moya; Jasmin Ma; Lindsey J Anderson; Daniel Wu; Jose M Garcia; Joanna D Davies
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-04-12       Impact factor: 12.910

Review 6.  Functional capacity, physical activity and muscle strength assessment of individuals with non-small cell lung cancer: a systematic review of instruments and their measurement properties.

Authors:  Catherine L Granger; Christine F McDonald; Selina M Parry; Cristino C Oliveira; Linda Denehy
Journal:  BMC Cancer       Date:  2013-03-20       Impact factor: 4.430

7.  Morbidity, mortality, and categorization of the risk of perioperative complications in lung cancer patients.

Authors:  Fabiana Stanzani; Denise de Moraes Paisani; Anderson de Oliveira; Rodrigo Caetano de Souza; João Aléssio Juliano Perfeito; Sonia Maria Faresin
Journal:  J Bras Pneumol       Date:  2014 Jan-Feb       Impact factor: 2.624

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.